Cargando…

Clinical evaluation of autoantibodies to a novel PM/Scl peptide antigen

Anti-PM/Scl antibodies represent a specific serological marker for a subset of patients with scleroderma (Scl) and polymyositis (PM), and especially with the PM/Scl overlap syndrome (PM/Scl). Anti-PM/Scl reactivity is found in 24% of PM/Scl patients and is found in 3–10% of Scl and PM patients. The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mahler, Michael, Raijmakers, Reinout, Dähnrich, Cornelia, Blüthner, Martin, Fritzler, Marvin J
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1174964/ https://www.ncbi.nlm.nih.gov/pubmed/15899056 http://dx.doi.org/10.1186/ar1729

Ejemplares similares

The changing landscape of the clinical value of the PM/Scl autoantibody system
por: Mahler, Michael, et al.
Publicado: (2009)

Autoantibodies directed to novel components of the PM/Scl complex, the human exosome
por: Brouwer, Rick, et al.
Publicado: (2002)

Antibodies against PM/Scl-75 and PM/Scl-100 are independent markers for different subsets of systemic sclerosis patients
por: Hanke, Katharina, et al.
Publicado: (2009)

Caspase-mediated cleavage of the exosome subunit PM/Scl-75 during apoptosis
por: Schilders, Geurt, et al.
Publicado: (2007)

Identification of a SmD3 epitope with a single symmetrical dimethylation of an arginine residue as a specific target of a subpopulation of anti-Sm antibodies
por: Mahler, Michael, et al.
Publicado: (2005)

Deciphering the Autoantibody Response to the OJ Antigenic Complex
por: Fritzler, Marvin J., et al.
Publicado: (2023)

Current Concepts and Future Directions for the Assessment of Autoantibodies to Cellular Antigens Referred to as Anti-Nuclear Antibodies
por: Mahler, Michael, et al.
Publicado: (2014)

Clinical evaluation of CENP-B and Scl-70 autoantibodies in silicosis patients
por: Lee, Suni, et al.
Publicado: (2017)

Detection of autoantibodies using chemiluminescence technologies
por: Mahler, Michael, et al.
Publicado: (2016)

Autoantibodies in Systemic Autoimmune Disorders
por: Mahler, Michael, et al.
Publicado: (2014)

The Utilization of Autoantibodies in Approaches to Precision Health
por: Fritzler, Marvin J., et al.
Publicado: (2018)

Autoantibody Discovery, Assay Development and Adoption: Death Valley, the Sea of Survival and Beyond
por: Fritzler, Marvin J., et al.
Publicado: (2021)

Clinical associations and potential novel antigenic targets of autoantibodies directed against rods and rings in chronic hepatitis C infection
por: Stinton, Laura M, et al.
Publicado: (2013)

Significance of Autoantibodies to Ki/SL as Biomarkers for Systemic Lupus Erythematosus and Sicca Syndrome
por: Mahler, Michael, et al.
Publicado: (2022)

Tofacitinib Is an Effective Treatment for Refractory Scleromyositis Associated With Anti-PM/Scl
por: Álvarez Troncoso, Jorge, et al.
Publicado: (2023)

Scleroderma Renal Crisis in a Systemic Sclerosis With Anti-PM/Scl Antibodies
por: Jacquier, Marine, et al.
Publicado: (2019)

Rpp25 is a major target of autoantibodies to the Th/To complex as measured by a novel chemiluminescent assay
por: Mahler, Michael, et al.
Publicado: (2013)

Autoantibodies in Systemic Sclerosis: Unanswered Questions
por: Kayser, Cristiane, et al.
Publicado: (2015)

The use and abuse of commercial kits used to detect autoantibodies
por: Fritzler, Marvin J, et al.
Publicado: (2003)

Effect of dsDNA binding to SmD-derived peptides on clinical accuracy in the diagnosis of systemic lupus erythematosus
por: Mahler, Michael, et al.
Publicado: (2007)

Toward a new autoantibody diagnostic orthodoxy: understanding the bad, good and indifferent
por: Fritzler, Marvin J.
Publicado: (2012)

Eculizumab for rescue of thrombotic microangiopathy in PM-Scl antibody-positive autoimmune overlap syndrome
por: Thomas, Christie P., et al.
Publicado: (2015)

Anti-PM/Scl Antibody-positive Systemic Sclerosis Complicated by Multiple Organ Involvement
por: Shimizu, Tatsuya, et al.
Publicado: (2020)

Antiphospholipase A(2) Receptor Autoantibodies: A Comparison of Three Different Immunoassays for the Diagnosis of Idiopathic Membranous Nephropathy
por: Behnert, Astrid, et al.
Publicado: (2014)

Clinical and serological evaluation of a novel CENP-A peptide based ELISA
por: Mahler, Michael, et al.
Publicado: (2010)

A New Chemiluminescence Immunoassay for Phospholipase A(2) Receptor 1 Autoantibodies Allows Early Identification of Autoantibody Recurrence in Patients With Membranous Nephropathy
por: Hoxha, Elion, et al.
Publicado: (2021)

The Spectrum of Anti-Chromatin/Nucleosome Autoantibodies: Independent and Interdependent Biomarkers of Disease
por: Mehra, Sonal, et al.
Publicado: (2014)

An Anti-PM/Scl-75 Antibody-positive Japanese Woman Who Developed Inflammatory Myopathy
por: Nakamura, Yuki, et al.
Publicado: (2019)

Rituximab and intravenous immunoglobulin treatment in PM/Scl antibody-associated disease: case-based review
por: Srikantharajah, Denesh, et al.
Publicado: (2022)

Progress in understanding the diagnostic and pathogenic role of autoantibodies associated with systemic sclerosis
por: Choi, May Y., et al.
Publicado: (2016)

Emerging technologies in autoantibody testing for rheumatic diseases
por: Olsen, Nancy J., et al.
Publicado: (2017)

Update on autoantibodies and related biomarkers in autoimmune inflammatory myopathies
por: Choi, May Y., et al.
Publicado: (2023)

The significance of autoantibodies to DFS70/LEDGFp75 in health and disease: integrating basic science with clinical understanding
por: Ochs, Robert L., et al.
Publicado: (2015)

The Clinical Significance of the Dense Fine Speckled Immunofluorescence Pattern on HEp-2 Cells for the Diagnosis of Systemic Autoimmune Diseases
por: Mahler, Michael, et al.
Publicado: (2012)

Development of a Recombinant Cell-Based Indirect Immunofluorescence Assay for the Determination of Autoantibodies against Soluble Liver Antigen in Autoimmune Hepatitis
por: Radzimski, Christiane, et al.
Publicado: (2013)

The Effect of Anti‐Scl‐70 Antibody Determination Method on Its Predictive Significance for Interstitial Lung Disease Progression in Systemic Sclerosis
por: Jandali, Bochra, et al.
Publicado: (2022)

OA17 An evolving case of Anti PM/Scl Anti body associated Aggressive Systemic Sclerosis
por: Subasinghe, Sunari, et al.
Publicado: (2022)

AIT test has no problem in the detection of anti-ribosomal P – authors' response
por: Mahler, Michael, et al.
Publicado: (2009)

Anti-PM/Scl antibodies are found in Japanese patients with various systemic autoimmune conditions besides myositis and scleroderma
por: Muro, Yoshinao, et al.
Publicado: (2015)

Interstitial Lung Disease Is a Major Characteristic of Patients Who Test Positive for Anti-PM/Scl Antibody
por: Ge, Yongpeng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q8m94ns4jfrpom4t7qjahkrim8